Taking my diabetes treatment into my own hands

Original Article ↗ Hacker News Discussion ↗

Adult-Onset T1D and Autoimmunity

  • Multiple accounts of “late” Type 1 onset, sometimes coinciding with other autoimmune diseases (e.g., rheumatoid arthritis).
  • Commenters note adult-onset T1D is common and was a driver for renaming “juvenile diabetes” to Type 1.
  • Viral infections (Epstein–Barr, CMV, flu) are mentioned as suspected triggers, but mechanisms are acknowledged as complex and not fully understood.

DIY Modeling and Optimization

  • The blog’s use of biophysical glucose–insulin models and open‑source libraries sparked debate.
  • Some argue using differential-equation models as black boxes without understanding them is risky; others point out this still exceeds typical clinical practice.
  • Suggestions for better optimization: treat doses as continuous variables; use derivative‑free / black‑box optimization (e.g., Bayesian optimization, standard numerical methods) instead of brute‑force genetic algorithms.
  • Probabilistic programming tools (PyMC, Stan) are mentioned for parameter estimation and uncertainty, but seen as an advanced topic.

Everyday Management Strategies

  • Strong support for pre‑bolusing ~15 minutes before eating; several T1Ds report dramatically smoother post‑meal glucose, despite clinicians sometimes downplaying it due to practical risks.
  • Additional tactics: walking after meals, splitting basal doses, extending boluses for fat/protein, confirming CGM extremes with fingersticks.
  • Emotional burden is a recurring theme: constant decision‑making, “vibes‑based” dosing, and periodic “screw it” moments around food.

Closed-Loop / Artificial Pancreas Systems

  • Several commenters already use commercial closed-loop systems (Medtronic, Tandem, Omnipod + Dexcom) and DIY setups (Loop, AndroidAPS, iAPS), often reporting life‑changing improvements in time‑in‑range and mental health.
  • Distribution is uneven: easier access in some US/UK settings than elsewhere; regulatory and reimbursement barriers remain.
  • Limitations noted: alarm fatigue, CGM inaccuracies, limited algorithm flexibility, UX issues; some still prefer DIY loops for configurability and sensor overlap.

Diet, Exercise, and T2D / Prediabetes

  • Many T2D and prediabetic commenters report major benefits or remission from low‑carb or ketogenic diets, sometimes combined with metformin or GLP‑1 drugs; others succeed on whole‑food, high‑carb plant‑based diets.
  • Broad agreement that weight loss, intense and regular exercise, and reducing fast carbs improve insulin sensitivity.
  • Multiple people stress that T1D absolutely still requires insulin, even on strict keto; attempts to replace insulin with diet alone are described as dangerous.
  • Some mention specific adjuncts (oats/beta‑glucan, turmeric, psyllium), but evidence quality is mixed and often anecdotal.

Risks: Hypoglycemia, DKA, and CGM Limits

  • Stories of nocturnal hypoglycemic coma and diabetic ketoacidosis highlight life‑threatening risks, especially during strenuous trips (heat/cold damaging insulin, lack of carbs, limited monitoring).
  • Concerns about CGM accuracy (false lows/highs), especially with “no calibration” sensors, fuel skepticism about fully automated dosing.
  • Alarm fatigue leads some to disable alerts, consciously shifting responsibility back to manual checks.

Healthcare System and Self-Advocacy

  • Strong consensus that T1Ds must learn to manage themselves; many feel routine care is too infrequent, formulaic, or tech‑illiterate to handle real‑world variability.
  • Some defend clinicians as overworked and under‑resourced; others describe shallow diagnostics, dismissal, and reliance on outdated care pathways.
  • Disappointment with “sick‑care” models drives people toward self‑logging, CGMs, DIY tools, and extensive personal research.